A detailed history of Versant Capital Management, Inc transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 159 shares of RARE stock, worth $6,782. This represents 0.0% of its overall portfolio holdings.

Number of Shares
159
Previous 78 103.85%
Holding current value
$6,782
Previous $4,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 02, 2025

BUY
$42.07 - $57.72 $3,407 - $4,675
81 Added 103.85%
159 $6,000
Q2 2024

Jul 05, 2024

BUY
$37.42 - $51.61 $2,918 - $4,025
78 New
78 $3,000
Q2 2023

Jul 10, 2023

BUY
$37.35 - $52.15 $448 - $625
12 New
12 $0

Others Institutions Holding RARE

About Ultragenyx Pharmaceutical Inc.


  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $2.99B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.